Cargando…
Protective effect of bisphosphonate on the cortical bone at key locations of the femur in aromatase inhibitor-associated bone loss: A three-dimensional cortical bone mapping study
Aromatase inhibitor treatment in breast cancer is associated with accelerated bone loss and an increased risk of fracture. Bisphosphonates (BPs) are the mainstay treatment of aromatase inhibitor-associated bone loss (AIBL), which might improve femoral bone at key locations prone to fracture. To test...
Autores principales: | Hong, Namki, Burm, Seung Won, Treece, Graham, Ye Kim, Jee, Hwan Kim, Min, Lee, Seunghyun, Shin, Sungjae, Rhee, Yumie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728402/ https://www.ncbi.nlm.nih.gov/pubmed/35024328 http://dx.doi.org/10.1016/j.jbo.2021.100409 |
Ejemplares similares
-
ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022) -
Association of Insulin Resistance with Lower Bone Volume and Strength Index of the Proximal Femur in Nondiabetic Postmenopausal Women
por: Yang, Jaewon, et al.
Publicado: (2018) -
ODP077 Adipopenia is associated with low bone mass in community-dwelling non-underweight adults, independent of sarcopenia
por: Lee, Seunghyun, et al.
Publicado: (2022) -
OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023) -
Radiographic changes of mandibular cortical bone in bisphosphonate drug holiday
por: Lee, Dae-Hoon, et al.
Publicado: (2022)